Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
RoosterBioroosterbio.com · Low evidenceRoosterBio supplies human mesenchymal stem/stromal cells (hMSCs) from bone marrow, adipose tissue, umbilical cord, and other sources, along with exosomes, cell banks, and media to enable MSC- and exosome-based therapy development. They offer end-to-end, cGMP-ready products and services, including hMSC expansion media, bioreactor feeds, genetic engineering media, exosome media, downstream processing, and analytical/CMC support to shorten development timelines and lower costs. With a global ecosystem and regulatory expertise, they support hundreds of partners in more than 25 countries, providing QuickShip solutions and scalable platforms to accelerate translation from research to clinic and market.
Parse Score